Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer – a Swedish Gynecologic Cancer Group (SweGCG) study

Authors

  • Karin Stålberg Department of Women’s and Children’s Health, Uppsala University, Uppsala, Sweden
  • Maria Bjurberg Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital Lund, Lund, Sweden;  Department of Clinical Sciences, Lund University, Lund, Sweden
  • Christer Borgfeldt Department of Clinical Sciences, Lund University, Lund, Sweden;  Department of Obstetrics and Gynecology, Skåne University Hospital, Lund, Sweden
  • Joseph Carlson Department of Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden;  Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
  • Pernilla Dahm-Kähler Department of Obstetrics and Gynecology, Sahlgrenska Academy at Göteborg University, Sahgrenska University Hospital, Göteborg, Sweden
  • Angelique Flöter-Rådestad Department of Obstetrics and Gynecology, Karolinska Institutet, Stockholm, Sweden
  • Kristina Hellman Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden;  Department of Oncology and Pathology, Karolinska University Hospital, Stockholm, Sweden
  • Elisabet Hjerpe Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden;  Department of Oncology and Pathology, Karolinska University Hospital, Stockholm, Sweden
  • Erik Holmberg Department of Oncology, Sahlgrenska Academy, Institute of Clinical Sciences, Goteborg, Sweden;  Sahlgrenska University Hospital, Regionalt Cancercentrum Väst, Goteborg, Sweden
  • Preben Kjølhede Department of Obstetrics and Gynecology, Linköping University, Linköping, Sweden;  Department of Clinical and Experimental Medicine, Linköping University, Linkoping, Sweden
  • Janusz Marcickiewicz Regionalt cancercentrum vast, Goteborg, Sweden;  Department of Obstetrics and Gynecology, Hallands Hospital Varberg, Varberg, Sweden
  • Per Rosenberg Department of Clinical and Experimental Medicine, Linköping University, Linkoping, Sweden;  Department of Clinical Oncology, Linköping University, Linkoping, Sweden
  • Bengt Tholander Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
  • Elisabeth Åvall-Lundqvist Department of Clinical and Experimental Medicine, Linköping University, Linkoping, Sweden;  Department of Clinical Oncology, Linköping University, Linkoping, Sweden
  • Thomas Högberg Department of Cancer Epidemiology, Lund University, Lund, Sweden

DOI:

https://doi.org/10.1080/0284186X.2019.1643036

Abstract

Background: The aim of this study is to evaluate the impact of lymphovascular space invasion (LVSI) on the risk of lymph node metastases and survival in endometrioid endometrial adenocarcinoma.

Material and methods: As regard the study design, this is a cohort study based on prospectively recorded data. Patients with endometrioid endometrial adenocarcinoma registered in the Swedish Quality Registry for Gynecologic Cancer 2010–2017 with FIGO stages I–III and verified nodal status were identified (n = 1587). LVSI together with established risk factors, namely DNA ploidy, FIGO grade, myometrial invasion and age, were included in multivariable regression analyses with lymph node metastases as the dependent variable. Associations between the risk factors and overall and relative survival were included in multivariable models. Estimates of risk ratios (RR), hazard ratios (HR), excess mortality rate ratios (EMR), and 95% confidence intervals (95% CI) were calculated.

Results: The presence of LVSI presented the strongest association with lymph node metastases (RR = 5.46, CI 3.69–8.07, p < .001) followed by deep myometrial invasion (RR = 1.64, CI 1.13–2.37). In the multivariable survival analyses, LVSI (EMR = 7.69, CI 2.03–29.10,) and non-diploidy (EMR = 3.23, CI 1.25–8.41) were associated with decreased relative survival. In sub-analyses including only patients with complete para-aortic and pelvic lymphadenectomy and negative lymph nodes (n = 404), only LVSI (HR = 2.50, CI 1.05–5.98) was associated with a worsened overall survival.

Conclusion: This large nationwide study identified LVSI as the strongest independent risk factor for lymph node metastases and decreased survival in patients with endometrioid adenocarcinomas. Moreover, decreased overall survival was also seen in patients with LVSI-positive tumors and negative lymph nodes, indicating that hematogenous dissemination might also be important.

Downloads

Download data is not yet available.

Downloads

Published

2019-11-02

How to Cite

Stålberg, K., Bjurberg, M., Borgfeldt, C., Carlson, J., Dahm-Kähler, P., Flöter-Rådestad, A., … Högberg, T. (2019). Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer – a Swedish Gynecologic Cancer Group (SweGCG) study. Acta Oncologica, 58(11), 1628–1633. https://doi.org/10.1080/0284186X.2019.1643036